Trademark Overview
On Tuesday, October 28, 2025, a trademark application was filed for DIRECTVLP with the United States Patent and Trademark Office. The USPTO has given the DIRECTVLP trademark a serial number of 99466065. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 25, 2026. This trademark is owned by Esperovax, Inc.. The DIRECTVLP trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Oral vaccines; Modified cells for medical or clinical use; Yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
